Aspen Aerogels, Inc. (NYSE:ASPN) Expected to Announce Earnings of -$0.47 Per Share

Wall Street brokerages expect that Aspen Aerogels, Inc. (NYSE:ASPN – Get Rating) will post earnings per share (EPS) of ($0.47) for the current quarter, according to Zacks. Five analysts have provided estimates for Aspen Aerogels’ earnings. The lowest EPS estimate is ($0.58) and the highest is ($0.35). Aspen Aerogels posted earnings of ($0.22) per share in the same quarter last year, which would suggest a negative year over year growth rate of 113.6%. The firm is scheduled to issue its next quarterly earnings report before the market opens on Monday, January 1st.

On average, analysts expect that Aspen Aerogels will report full-year earnings of ($1.87) per share for the current financial year, with EPS estimates ranging from ($1.98) to ($1.73). For the next year, analysts expect that the company will report earnings of ($1.17) per share, with EPS estimates ranging from ($1.63) to ($0.70). Zacks’ earnings per share averages are an average based on a survey of research firms that follow Aspen Aerogels.

Aspen Aerogels (NYSE:ASPN – Get Rating) last released its quarterly earnings data on Thursday, February 17th. The construction company reported ($0.50) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.30) by ($0.20). The business had revenue of $31.48 million during the quarter, compared to the consensus estimate of $35.71 million. Aspen Aerogels had a negative return on equity of 33.70% and a negative net margin of 30.50%. During the same period last year, the business posted ($0.23) earnings per share.

Several brokerages have commented on ASPN. HC Wainwright cut their price target on shares of Aspen Aerogels from $65.00 to $45.00 and set a “buy” rating for the company in a report on Friday, February 18th. Zacks Investment Research downgraded shares of Aspen Aerogels from a “hold” rating to a “sell” rating in a report on Thursday, February 24th. B. Riley reissued a “top pick” rating on shares of Aspen Aerogels in a report on Monday, January 3rd. Canaccord Genuity Group cut their price target on shares of Aspen Aerogels from $52.00 to $47.00 in a report on Friday, February 18th. Finally, Benchmark lowered their price objective on shares of Aspen Aerogels from $70.00 to $60.00 in a research report on Friday, February 18th. One analyst has rated the stock with a sell rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $51.18.

NYSE:ASPN traded down $0.17 during trading hours on Monday, hitting $26.25. The stock had a trading volume of 293,512 shares, compared to its average volume of 376,059. The company has a 50 day simple moving average of $30.04 and a two-hundred day simple moving average of $41.54. Aspen Aerogels has a one year low of $16.33 and a one year high of $65.99. The firm has a market capitalization of $872.39 million, a price-to-earnings ratio of -22.06 and a beta of 1.77.

In other Aspen Aerogels news, major shareholder Koch Industries Inc bought 1,791,986 shares of the firm’s stock in a transaction that occurred on Monday, March 28th. The shares were bought at an average price of $27.90 per share, for a total transaction of $49,996,409.40. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Robert M. Gervis bought 135,870 shares of the firm’s stock in a transaction that occurred on Tuesday, March 22nd. The stock was acquired at an average price of $33.12 per share, for a total transaction of $4,500,014.40. The disclosure for this purchase can be found here. 13.30% of the stock is owned by company insiders.

Several hedge funds have recently added to or reduced their stakes in the business. State Board of Administration of Florida Retirement System increased its position in shares of Aspen Aerogels by 2.0% in the third quarter. State Board of Administration of Florida Retirement System now owns 9,401 shares of the construction company’s stock valued at $433,000 after acquiring an additional 180 shares during the period. UBS Group AG increased its position in shares of Aspen Aerogels by 0.5% in the third quarter. UBS Group AG now owns 83,503 shares of the construction company’s stock valued at $3,842,000 after acquiring an additional 393 shares during the period. Metropolitan Life Insurance Co NY increased its position in shares of Aspen Aerogels by 6.5% in the third quarter. Metropolitan Life Insurance Co NY now owns 6,529 shares of the construction company’s stock valued at $300,000 after acquiring an additional 400 shares during the period. Banque Cantonale Vaudoise purchased a new position in shares of Aspen Aerogels in the third quarter valued at about $31,000. Finally, Advisor Group Holdings Inc. increased its position in shares of Aspen Aerogels by 70.9% in the fourth quarter. Advisor Group Holdings Inc. now owns 1,847 shares of the construction company’s stock valued at $92,000 after acquiring an additional 766 shares during the period. Hedge funds and other institutional investors own 83.46% of the company’s stock.

Aspen Aerogels Company Profile (Get Rating)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production.

Recommended Stories